JP2012025749A5 - - Google Patents

Download PDF

Info

Publication number
JP2012025749A5
JP2012025749A5 JP2011160394A JP2011160394A JP2012025749A5 JP 2012025749 A5 JP2012025749 A5 JP 2012025749A5 JP 2011160394 A JP2011160394 A JP 2011160394A JP 2011160394 A JP2011160394 A JP 2011160394A JP 2012025749 A5 JP2012025749 A5 JP 2012025749A5
Authority
JP
Japan
Prior art keywords
compound
composition
isoform
unsubstituted
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011160394A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012025749A (ja
JP5751965B2 (ja
Filing date
Publication date
Priority claimed from EP10007718A external-priority patent/EP2415461B1/en
Application filed filed Critical
Publication of JP2012025749A publication Critical patent/JP2012025749A/ja
Publication of JP2012025749A5 publication Critical patent/JP2012025749A5/ja
Application granted granted Critical
Publication of JP5751965B2 publication Critical patent/JP5751965B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011160394A 2010-07-24 2011-07-22 血清に基づく溶液中のインターロイキン6の安定化 Active JP5751965B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10007718A EP2415461B1 (en) 2010-07-24 2010-07-24 Stabilization of interleukin 6 in serum based solutions
EP10007718.9 2010-07-24

Publications (3)

Publication Number Publication Date
JP2012025749A JP2012025749A (ja) 2012-02-09
JP2012025749A5 true JP2012025749A5 (https=) 2013-09-05
JP5751965B2 JP5751965B2 (ja) 2015-07-22

Family

ID=43063518

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011160394A Active JP5751965B2 (ja) 2010-07-24 2011-07-22 血清に基づく溶液中のインターロイキン6の安定化

Country Status (4)

Country Link
US (1) US8377882B2 (https=)
EP (1) EP2415461B1 (https=)
JP (1) JP5751965B2 (https=)
ES (1) ES2398646T3 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3605097B1 (en) * 2017-03-27 2024-11-13 NH Foods Ltd. Substance that prevents antigen-antibody reaction inhibition by body fluid
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー 凍結乾燥方法
CN113614477B (zh) 2019-03-14 2023-04-28 泰尔茂比司特生物技术有限公司 冷冻干燥装载托盘组件及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
DE3939706C1 (https=) 1989-12-01 1991-03-21 Centre Regional De Transfusion Sanguine, Besancon, Fr
DE4022878A1 (de) 1990-07-18 1992-01-23 Boehringer Mannheim Gmbh Konservierung von diagnostischen tests
DE19746868A1 (de) * 1997-10-23 1999-04-29 Knoll Ag Verwendung von TNF-Antagonisten als Arzneimittel zur Behandlung von septischen Erkrankungen
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
KR100771294B1 (ko) * 1999-12-14 2007-10-29 써모 바이오스타, 인크. 폴리펩티드 및 항원 안정화 희석제
EP2236618A3 (en) * 2001-01-31 2011-06-08 Asahi Kasei Pharma Corporation Compositions for assaying glycoprotein
JP4453999B2 (ja) * 2001-02-14 2010-04-21 栄研化学株式会社 尿中蛋白及びペプチドの安定化方法
US7601491B2 (en) 2003-02-06 2009-10-13 Becton, Dickinson And Company Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
MXPA05001815A (es) 2004-02-20 2005-08-24 Hoffmann La Roche Adsorcion de acidos nucleicos a una fase solida.
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
DE602006005806D1 (de) 2006-07-28 2009-04-30 Vista Ventures Gmbh Verfahren zum Nachweis der amyloid-beta Oligomere in Körperflüssigkeiten
WO2009048962A1 (en) 2007-10-12 2009-04-16 Vladislav Dolnik Capillary sieving electrophoresis with a cationic surfactant for size separation of proteins
CN102089319B (zh) * 2008-05-08 2013-11-13 味之素株式会社 蛋白质的重折叠方法

Similar Documents

Publication Publication Date Title
JP2013539454A5 (https=)
JP2009543861A5 (https=)
CY1117915T1 (el) Συγχωνευμενες βενζοξαζεπινονες ως διαμορφωτες διαυλων ιοντων
JP2014520901A5 (https=)
EA201490910A1 (ru) Противообледенительная композиция
EA201170520A1 (ru) Ингибитор p38 mapk-киназы
JP2013509429A5 (https=)
JP2016518328A5 (https=)
EA201391389A1 (ru) Кристаллы антител против склеростина и составы на их основе
JP2017510661A5 (https=)
EA201391746A1 (ru) Противогололедная композиция
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
EA201391637A1 (ru) Ингибиторы вируса гепатита c
EA201991704A3 (ru) Моноклональные антитела против ингибитора пути тканевого фактора (tfpi)
JP2013541600A5 (https=)
EA201491112A1 (ru) Перколированный муллит и способ его получения
MX2013003764A (es) Metodos de elaboracion de fenilacetato de l-ornitina.
WO2013072768A3 (en) Synthetic derivatives of mpl and uses thereof
EA202090465A1 (ru) Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк- и/или днк-содержащими вирусами, и сопутствующих заболеваний
JP2015534939A5 (https=)
JP2012025749A5 (https=)
EA200700600A1 (ru) Фармацевтическая композиция, содержащая изомер бета-миметического агента и антихолинергический агент
CL2007000680A1 (es) Compuesto cristalino (5s)-5-[4(cloro-piridin-2-iloxi)-piperidin-1-sulfonilmetil]-5-metil-imidazolidin-2,4-diona, forma g; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de epoc.
MX2015016958A (es) Sintesis de dicarbamatos de isohexida y derivados de estos.
EA201491442A1 (ru) Твердые формы, содержащие ингибиторы ns5a вируса гепатита с, их композиции и их применение